Michael Schaeffer
Director/Board Member bij VIVORYON THERAPEUTICS N.V.
Vermogen: - $ op 31-03-2024
Profiel
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-03-2024 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Michael Schaeffer
| Bedrijven | Functie | Begin |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director/Board Member | - |
Eerdere bekende functies van Michael Schaeffer
| Bedrijven | Functie | Einde |
|---|---|---|
Crelux GmbH
 Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Chief Executive Officer | 01-03-2016 |
| SiREEN AG | Chief Executive Officer | 01-01-2004 |
Opleiding van Michael Schaeffer
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| SiREEN AG | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Health Technology |
